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LETTERS
Methicillin- 
Resistant  
Staphylococcus  
aureus USA400 
Clone, Italy
To  the  Editor:  In  the  past  30 
years,  methicillin-resistant  Staphylo-
coccus aureus (MRSA) has been the 
leading cause of nosocomial infections 
throughout the world. Healthcare-as-
sociated MRSA (HA-MRSA) isolates 
are resistant to multiple antimicrobial 
drugs. This resistance severely ham-
pers  treatment  options.  During  the 
past decade, MRSA isolates have also 
emerged  as  major  pathogens  in  the 
community, first in the United States 
and later worldwide. Community-as-
sociated MRSA (CA-MRSA) isolates 
are usually more susceptible to antimi-
crobial drugs but are more virulent than 
HA-MRSA  isolates.  Among  various 
determinants  involved  in  the  patho-
genesis of CA-MRSA infections, spe-
cial attention has been focused on the 
Panton-Valentine  leukocidin  (PVL), 
which has a strong epidemiologic link 
with CA-MRSA clones (1).
It  has  been  suggested  that  CA-
MRSA  might  move  to  healthcare 
settings,  blurring  the  line  between 
HA-  and  CA-MRSA  (2).  Neverthe-
less, CA-MRSA isolates are increas-
ingly being reported as pathogens in 
the general population in persons with 
no risk factors for HA-MRSA acqui-
sition. These pathogens are generally 
associated with skin and soft tissue in-
fections, but also with more severe in-
fections such as necrotizing pneumo-
nia or septicemia. CA-MRSA strains 
usually harbor a staphylococcal cas-
sette chromosome (SCC) mec (type IV 
or V) that is smaller than the type I–III 
SCCmec  elements  commonly  found 
in HA-MRSA strains. To date, 5 major 
CA-MRSA  clonal  lineages  from  di-
verse genetic backgrounds have been 
recognized  by  pulsed-field  gel  elec-
trophoresis  and  multilocus  sequence 
typing; certain clones predominate in 
specific areas of the world (1). 
The  most  common  lineages  in 
the  United  States  are  sequence  type 
(ST) 1 (USA400) and ST8 (USA300), 
which usually carry type IV SCCmec 
and  PVL-encoding  genes.  Over  the 
past  few  years,  ST8  (USA300)  has 
become  predominant  in  the  United 
States (3), also emerging as a major 
cause of nosocomial infections (4). In 
Europe, data are more limited, but the 
situation appears to be more varied: 
the  predominant  CA-MRSA  clonal 
lineage  is  ST80  (5),  although  single 
cases or small clusters caused by ST8 
(USA300)  have  increasingly  been 
reported  (6–8).  In  contrast,  the  ST1 
(USA400) clone is still rare in Europe 
(9,10). We describe the importation of 
ST1 (USA400) into Italy and its isola-
tion in the country. The organism was 
isolated from an Italian woman with 
a skin infection that she contracted in 
the United States.
In late November 2007, a 36-year-
old Italian woman was seen at Porde-
none Hospital (northeastern Italy) for 
spider-bite–like  skin  lesions  on  the 
face, characterized by rapid evolution 
to furuncles and small abscesses. The 
infection had started ≈1 month earlier 
in  California,  where  she  had  spent 
several months on business (wine im-
port-export), and where she had been 
treated  empirically  with  amoxicillin/
clavulanate for 10 days (1 g, 3×/day), 
with no clinical improvement. 
Culture of the pus from the ab-
scesses yielded an MRSA isolate that 
was resistant to oxacillin and suscep-
tible to all non-β-lactam antimicrobial 
drugs tested by Vitek 2 AST-P536 card 
(bioMérieux, Marcy l’Etoile, France). 
Such a particular susceptibility pattern 
and the community origin of the infec-
tion prompted molecular investigation 
and  typing  by  established  methods, 
which confirmed the isolate to be CA-
MRSA and identified it as belonging 
to the USA400 clone (ST1, type IVa 
SCCmec,  presence  of  PVL  genes, 
agr type III, spa type t128). Notably, 
t128 is the spa type found in MW2, 
the highly virulent prototype strain of 
USA400.  Treatment  with  oral  levo-
floxacin for 7 days (500 mg, 1×/day) 
led to complete resolution of the infec-
tion. After more than a year, the patient 
has experienced no recurrences.
All  3  previously  reported  cases 
of CA-MRSA infection in Italy were 
caused by type IV SCCmec, PVL-pos-
itive strains, none of which, however, 
belonged to the ST80 clonal lineage 
that predominates in Europe (7). The 
first case (in 2005) was a necrotizing 
pneumonia caused by an ST30 isolate; 
the 2 other cases (2006) were severe 
invasive  sepsis  and  a  neck  abscess, 
both  caused  by  ST8  (USA300)  iso-
lates.  The  case  we  note  here  docu-
ments the importation of a US patho-
gen into a country in Europe, from an 
area where the pathogen is widespread 
and has been highly virulent since the 
late 1990s, to an area where its pen-
etration in the past has been poor.
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Meningitis and 
Radiculomyelitis 
Caused by  
Angiostrongylus 
cantonensis
To  the  Editor:  Angiostrongy-
lus cantonensis infection is endemic 
in  regions  such  as  Southeast  Asia, 
China, the Pacific Basin, and the Ca-
ribbean, but international travel has 
spread the disease elsewhere, includ-
ing Europe (1–10). Dissemination of 
the parasite to many regions has also 
occurred  because  of  the  ship-borne 
international  migration  of  rats  and 
the diversity of potential intermediate 
hosts. The target organ in humans is 
the central nervous system in which 
an eosinophilic reaction develops in 
response to dying larvae. We report 
a  case  of  eosinophilic  meningitis 
and lumbosacral myeloradiculopathy 
caused by A. cantonensis and present 
a review of cases of A. cantonensis 
infections from Europe.
A  47-year-old  merchant  seaman 
was admitted to the University Hos-
pital  of  Infectious  Diseases,  Zagreb, 
Croatia, in March, 2006 on the 17th 
day of illness because of fever, head-
ache,  vomiting,  and  constipation. At 
the  end  of  the  first  week  of  illness, 
paresthesias developed in his feet; on 
the 10th day of illness, he also noticed 
difficulties with urination. He had re-
turned from a 1-month trip to South-
east  Asia  (Malaysia  and  Singapore) 
35 days before the onset of symptoms 
and  recalled  eating  vegetables  and 
salads.  He  also  consumed  shrimp, 
but he believed that they were from 
salt water. On physical examination, 
we  noticed  increased  muscle  tone, 
tremor of the tongue and upper limbs, 
and  decreased  deep  tendon  reflexes 
of  the  lower  limbs.  He  experienced 
urinary retention, and catheterization 
was required. Saddle anesthesia was 
observed. There was no neck stiffness, 
and the results of the rest of the physi-
cal examination were  normal.
His  blood  leukocyte  count  was 
11.5  ×  109/L  with  80%  neutrophils, 
12%  lymphocytes,  4%  monocytes, 
2%  basophils,  and  2%  eosinophils. 
Cerebrospinal  fluid  (CSF)  analysis 
showed  320  cells/μL  with  6.5% 
eosinophils  (21  eosinophils/μL). 
Results  of  CSF  testing  by  PCR  for 
herpes simplex virus 1 (HSV-1) and 
HSV-2 DNA were negative, as were 
cultures  for  bacteria,  mycobacteria, 
and fungi. Results of serum and CSF 
antibody tests for Borrelia burgdorferi, 
Treponema pallidum, HSV-1, HSV-2,   
tick-borne  encephalitis  virus,  Toxo-
plasma gondii, Taenia solium, Toxo- 
cara spp., and Trichinella spp. were   
also  negative.  Results  of  stool 
examination for Ascaris lumbricoides, 
Trichuris  trichiura,  Taenia  spp., 
Giardia  intestinalis,  Strongyloides 
spp., and Entamoeba histolytica were   
negative.  The  patient  was  also 
negative for HIV by ELISA. Magnetic 
resonance imaging scans of the brain 
and  spine  were  unremarkable.  A. 
cantonensis  infection  was  diagnosed   
by  immunoblot  testing  at  the 
Department of Helminthology, Facul-
ty  of  Tropical  Medicine,  Mahidol 
University,  Bangkok.  Antibodies 
against A. cantonensis 31-kDa antigen 
were  detected  in  serum  and  CSF 
of  the  patient;  antibodies  against 
Gnathostoma  spinigerum  were  not 
detected.
Treatment  was  symptomatic;  to 
lessen the headache, 4 lumbar punc-
tures were performed. After 1 month, 
the  patient’s  general  condition  was 
greatly  improved;  however,  minor 
symptoms such as diminished concen-
tration, slow thinking, and mild head-
ache persisted. Urinary retention lasted 
for 38 days, and the patient had occa-
sional mild headaches and paresthesia 
in his feet for the next 5 months.
Because  large  numbers  of  per-
sons  from  Europe  travel  to  destina-
tions where angiostrongyliasis is en-
demic, it is somewhat surprising that 
the infection has been rarely described 
in Europe. In a Google and Medline 
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